Literature DB >> 21263998

Dysfunctional uterine bleeding.

V H Livingstone.   

Abstract

Dysfunctional uterine bleeding (DUB) is defined as abnormal uterine bleeding that results from an ovarian endocrinopathy. It may be associated with ovulatory and anovulatory cycles. The diagnosis of DUB depends on a thorough history and physical examination to exclude organic disorders. In older women, endometrial biopsy should be done before starting therapy. The treatment depends on an understanding of the menstrual cycle. In less urgent cases, anovulatory cycles are managed using progesterone replacement, and ovulatory cycles respond well to non-steroidal anti-inflammatory drugs (NSAIDs). In urgent cases oral or intravenous estrogen is used, and emergency dilation and currettage are done if the hemorrhage fails to stop.

Entities:  

Year:  1987        PMID: 21263998      PMCID: PMC2218686     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

1.  Treatment of dysfunctional uterine bleeding with danazol.

Authors:  I S Fraser
Journal:  Aust N Z J Obstet Gynaecol       Date:  1985-08       Impact factor: 2.100

2.  Coagulation and fibrinolysis in uterine blood.

Authors:  P Skjodt; O K Albrechtsen
Journal:  Acta Obstet Gynecol Scand       Date:  1965       Impact factor: 3.636

3.  Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.

Authors:  G R DeVore; O Owens; N Kase
Journal:  Obstet Gynecol       Date:  1982-03       Impact factor: 7.661

4.  Diagnostic dilation and curettage: a reappraisal.

Authors:  D A Grimes
Journal:  Am J Obstet Gynecol       Date:  1982-01-01       Impact factor: 8.661

5.  Levels of prostaglandins in human endometrium during the normal menstrual cycle.

Authors:  J Downie; N L Poyser; M Wunderlich
Journal:  J Physiol       Date:  1974-01       Impact factor: 5.182

6.  Menstrual blood loss--a population study. Variation at different ages and attempts to define normality.

Authors:  L Hallberg; A M Högdahl; L Nilsson; G Rybo
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

7.  Studies in the involvement of prostaglandins in uterine symptomatology and pathology.

Authors:  E A Willman; W P Collins; S G Clayton
Journal:  Br J Obstet Gynaecol       Date:  1976-05

8.  Dysfunctional uterine bleeding. Clarifying its definition, mechanisms, and management.

Authors:  R J Worley
Journal:  Postgrad Med       Date:  1986-02-15       Impact factor: 3.840

9.  Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.

Authors:  T H Chimbira; A B Anderson; A c Turnbull
Journal:  Br J Obstet Gynaecol       Date:  1980-07

10.  Efficacy of mefenamic acid in patients with a complaint of menorrhagia.

Authors:  I S Fraser; C Pearse; R P Shearman; P M Elliott; J McIlveen; R Markham
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.